ArticleArchives of diabetes & obesity2022
Safety of Intranasal Insulin in Type 2 Diabetes on Systemic Insulin: A Double-Blinded Placebo-Controlled Sub-Study of Memaid Trial.
L Aponte Becerra et al.PubMed ↗Full text ↗
No numbers read from the abstract.
3 papers cite it
this papertrialcites it